TY - JOUR
T1 - Mechanisms of carcinogenesis by crystalline silica in relation to oxygen radicals
AU - Saffiotti, U.
AU - Daniel, L. N.
AU - Mao, Y.
AU - Shi, X.
AU - Williams, A. O.
AU - Kaighn, M. E.
PY - 1994
Y1 - 1994
N2 - The carcinogenic effects of crystalline silica in rat lungs were extensively demonstrated by many experimental long-term studies, showing a marked predominance for adenocarcinomas originating from alveolar type II cells and associated with areas of pulmonary fibrosis (silicosis). In contrast with its effects in rats, silica did not induce alveolar type II hyperplasia and lung tumors in mice and hamsters, pointing to a critical role for host factors. Using these animal models, we are investigating the role of cytokines and other cellular mediators on the proliferation of alveolar type II cells. Immunohistochemical localization of TGF-β1 precursor in alveolar type II cells adjacent to silicotic granulomas was shown to occur in rats, but not in mice, and hamsters, suggesting a pathogenetic role for this regulatory growth factor. Recent investigations in our laboratory on the biologic mechanisms of crystalline silica included determination of anionic sites on crystalline silica surfaces by binding of the cationic dye Janus Green B; binding of crystalline silica to DNA, demonstrated by infrared spectrometry; production of oxygen radicals by crystalline silica in aqueous media; induction of DNA strand breakage and base oxidation in vitro and its potentiation by superoxide dismutase and by hydrogen peroxide; and induction by crystalline silica of neoplastic transformation and chromosomal damage in cells in culture. On the basis of these in vitro studies, we propose that DNA binding to crystalline silica surfaces may be important in silica carcinogenesis by anchoring DNA close to sites of oxygen radical production on the silica surface, so that the oxygen radicals are produced within a few A from their target DNA nucleotides.
AB - The carcinogenic effects of crystalline silica in rat lungs were extensively demonstrated by many experimental long-term studies, showing a marked predominance for adenocarcinomas originating from alveolar type II cells and associated with areas of pulmonary fibrosis (silicosis). In contrast with its effects in rats, silica did not induce alveolar type II hyperplasia and lung tumors in mice and hamsters, pointing to a critical role for host factors. Using these animal models, we are investigating the role of cytokines and other cellular mediators on the proliferation of alveolar type II cells. Immunohistochemical localization of TGF-β1 precursor in alveolar type II cells adjacent to silicotic granulomas was shown to occur in rats, but not in mice, and hamsters, suggesting a pathogenetic role for this regulatory growth factor. Recent investigations in our laboratory on the biologic mechanisms of crystalline silica included determination of anionic sites on crystalline silica surfaces by binding of the cationic dye Janus Green B; binding of crystalline silica to DNA, demonstrated by infrared spectrometry; production of oxygen radicals by crystalline silica in aqueous media; induction of DNA strand breakage and base oxidation in vitro and its potentiation by superoxide dismutase and by hydrogen peroxide; and induction by crystalline silica of neoplastic transformation and chromosomal damage in cells in culture. On the basis of these in vitro studies, we propose that DNA binding to crystalline silica surfaces may be important in silica carcinogenesis by anchoring DNA close to sites of oxygen radical production on the silica surface, so that the oxygen radicals are produced within a few A from their target DNA nucleotides.
KW - Alveolar type II cells
KW - Cristobalite
KW - Crystalline silica
KW - Cytokines
KW - DNA binding
KW - DNA damage
KW - Janus Green B
KW - Lung
KW - Lung carcinogenesis
KW - Neoplastic transformation,
KW - Quartz
KW - Silicosis
KW - TGF-β1
KW - Tridymite
UR - http://www.scopus.com/inward/record.url?scp=0028567071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028567071&partnerID=8YFLogxK
U2 - 10.1289/ehp.94102s10159
DO - 10.1289/ehp.94102s10159
M3 - Article
C2 - 7705291
AN - SCOPUS:0028567071
SN - 0091-6765
VL - 102
SP - 159
EP - 163
JO - Environmental Health Perspectives
JF - Environmental Health Perspectives
IS - SUPPL. 10
ER -